The BreatheSuite team recently had the opportunity to sponsor and exhibit at HLTH 2021, the preeminent event bringing together senior leaders to solve healthcare’s most pressing problems and realize the most promising opportunities to create health’s future. COVID-19 has permanently altered the future of healthcare and inspired the industry to push for impactful change, so it was not surprising to see many of those changes front and center at this year’s event. The pandemic has highlighted the need for greater investment in virtual care and Remote Patient Monitoring (RPM) solutions to deliver higher quality patient care more transparently at home and between in-person visits, and this desire for improvement was central to HLTH 2021 discussions. Brett Vokey, founder and CEO of BreatheSuite, and the team noticed the following virtual care trends emerging from our interactions at the event:
• The Power of Leveraging Data to Empower People and Providers: Increasingly, connected health advancements are enabling providers to transform digital patient data into actionable insights. RPM technologies are producing valuable data that is empowering users to improve treatment adherence at home and supporting clinicians’ efforts to personalize care.
• A Focus on Improving Care Quality While Also Reducing Costs: The industry is actively working to transition to value-based care. As a result, it is increasingly critical for providers to adopt solutions that not only improve the quality of care and health outcomes but also reduce costs at the same time.
• More Expansive Reimbursement Will Drive Greater Adoption: The Centers for Medicare & Medicaid Services (CMS) has proposed a new category of remote monitoring CPT codes for Remote Therapeutic Monitoring (RTM) as part of its 2022 Medicare Physician Fee Schedule. These codes will enable the reimbursement of monitoring of non-physiological data – expanding opportunities for clinicians to leverage remote patient monitoring programs. Now, more providers will adopt passive monitoring systems such as inhaler sensors instead of devices for non-passive measurements such as spirometry or pulse oximetry.
At BreatheSuite, we have created an over-the-counter connected health device that turns regular metered-dose inhalers (MDIs) into smart inhalers Our technology can score and help improve usage technique and adherence for the tens of millions of Americans who use MDIs in the treatment of Chronic Obstructive Pulmonary Disease (COPD), asthma and other respiratory diseases. Improving usage habits and allowing remote patient monitoring by physicians helps ensure the prescribed dosage of medication consistently reaches the lungs. This often results in better outcomes for people with respiratory conditions while helping to address the economic burden of inhaler misuse, which makes up about $5- $7 billion of the approximately $25 billion spent on inhalers annually. Collecting and sharing data on inhaler usage with patients and their physicians can also enable customized care plans, which are essential for the management of chronic diseases.
The pandemic has brought a new appreciation for in-person industry collaboration. Our conversations with other healthcare organizations have motivated our team to continue to push towards our goal of improving the lives of people with respiratory conditions while making the treatment process more efficient and data-driven than ever before.